Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RXST
RXST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RXST News
RxSight Announces Preliminary Q2 2026 Financial Results and Product Pipeline Updates
2d ago
Newsfilter
RxSight Q2 2026 Earnings Call Insights
1d ago
seekingalpha
RxSight Reports Q2 2026 Preliminary Results and Updates Guidance
1d ago
NASDAQ.COM
Alcon Partners with RxSight to Develop Adjustable Intraocular Lenses
1d ago
NASDAQ.COM
Alcon and RxSight Collaborate on Adjustable Intraocular Lenses Development
2d ago
seekingalpha
RxSight Updates 2026 Revenue Outlook Amid Q2 Preliminary Results
2d ago
seekingalpha
Alcon and RxSight Collaborate on Adjustable Intraocular Lens Development
2d ago
Newsfilter
Halper Sadeh LLC Investigates RxSight Executives' Fiduciary Duties
6d ago
PRnewswire
RxSight, Inc. Reports Q4 2025 Earnings with Strategic Insights
Feb 26 2026
seekingalpha
RxSight Issues 2026 Financial Guidance with Q4 Results
Feb 25 2026
seekingalpha
U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%
Jan 12 2026
Benzinga
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
RxSight Expects Q4 2025 Revenue of $32.6 Million, Appoints CFO
Jan 11 2026
NASDAQ.COM
RxSight Reports $134.5M Revenue for 2025, Announces CFO Transition
Jan 11 2026
Globenewswire
RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026
Jan 02 2026
Globenewswire
RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026
Jan 02 2026
Newsfilter
Show More News
